Stress Mediators Regulate Brain Prostaglandin Synthesis and Peroxisome Proliferator-Activated Receptor-γ Activation after Stress in Rats
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Stress exposure leads to oxidative/nitrosative and neuroinflammatory changes that have been shown to be regulated by antiinflammatory pathways in the brain. In particular, acute restraint stress is followed by cyclooxygenase (COX)-2 up-regulation and subsequent proinflammatory prostaglandin (PG) E2 release in rat brain cortex. Concomitantly, the synthesis of the antiinflammatory prostaglandin 15d-PGJ2 and the activation of its nuclear target the peroxisome proliferator-activated receptor (PPAR)-γ are also produced. This study aimed to determine the possible role of the main stress mediators: catecholamines, glucocorticoids, and excitatory amino acids (glutamate) in the above-mentioned stress-related effects. By using specific pharmacological tools, our results show that the main mediators of the stress response are implicated in the regulation of prostaglandin synthesis and PPARγ activation in rat brain cortex described after acute restraint stress exposure. Pharmacological inhibition (predominantly through β-adrenergic receptor) of the stress-released catecholamines in the central nervous system regulates 15d-PGJ2 and PGE2 synthesis, by reducing COX-2 overexpression, and reduces PPARγ activation. Stress-produced glucocorticoids carry out their effects on prostaglandin synthesis through their interaction with mineralocorticoid and glucocorticoid receptors to a very similar degree. However, in the case of PPARγ regulation, only the actions through the glucocorticoid receptor seem to be relevant. Finally, the selective blockade of the N-methyl-d-aspartate type of glutamate receptor after stress also negatively regulates 15d-PGJ2 and PGE2 production by COX-2 down-regulation and decrease in PPARγ transcriptional activity and expression. In conclusion, we show here that the main stress mediators, catecholamines, GCs, and glutamate, concomitantly regulate the activation of proinflammatory and antiinflammatory pathways in a possible coregulatory mechanism of the inflammatory process induced in rat brain cortex by acute restraint stress exposure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At least some of these stress effects are GC dependent and GR mediated (Garcia-Bueno et al., 2008).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as Garcia-Bueno et al., 2008
In the citing paper
“In support of this hypothesis, restraint stress and other physical stressors were shown to induce inflammatory mediators (e.g., iNOS, TNF-α, COX-2, PGE2, IL-1β, and CD14), reduce immunoregulatory proteins (e.g., CD200R) and trigger microglia proliferation in the rodent brain (147–152).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [149]
Citations
Cites
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
A Syndrome produced by Diverse Nocuous Agents
SELYE, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,903 · cited 1×
“In particular, the response to restraint stress is characterized by three related events: 1) activation of the sympathetic nervous system, which leads to an acute release of catecholamines (CATs) (epinephrine and norepinephrine) (1); 2) a slower but more sustained increase in plasma glucocorticoid (GCs) levels (1); an…”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614 · cited 5×
“For instance, the pharmacological modulation of GRs after systemic administration of drugs may cause changes in the stress system (GR-dependent negative feedback on the HPA axis) (60).”
BackgroundInfluentialBrain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 6×
“Afterward the membranes were blocked in 10 mm Tris-buffered saline containing 0.1% Tween 20 and 5% skim milk, the membranes were, respectively, incubated with specific goat polyclonal COX-1 (raised against a epitope mapping near the C-terminus of COX-1 of human origin); COX-2 (peptide placed at the C terminus of COX-2…”
BackgroundInfluentialThe role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 1×
“antiinflammatory prostaglandins) (6), and the activation of”
Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., & Worley, P. F. (1993) · Neuron · doi:10.1016/0896-6273(93)90192-t · Cited by 1,226
Emerging roles of PPARS in inflammation and immunity
Daynes, R. A., & Jones, D. C. (2002) · Nature Reviews Immunology · doi:10.1038/nri912 · Cited by 919
Vidal-Puig, A. J., Considine, R. V., Jimenez-Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 786 · cited 1×
“show) (79) and in vivo with the synthetic glucocorticoid dexa-”
BackgroundCyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779 · cited 1×
“ticity, regulation of fever, HPA axis activation, and sleep (16).”
BackgroundStress and the inflammatory response: A review of neurogenic inflammation
Black, P. H. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00021-1 · Cited by 688 · cited 2×
“may result in inflammatory diseases (3).”
BackgroundMoreno, S., Farioli-Vecchioli, S., & Cerù, M. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.064 · Cited by 587 · cited 1×
“PPAR is a transcription factor that belongs to the superfamily of hormone nuclear receptors (28) widely expressed in brain cortex (29), exerting antiinflammatory activities in brain cells by reducing the release of proinflammatory cytokines, inducible NO synthase (NOS)-2, and COX-2 expression or interfering with infla…”
BackgroundMoghaddam, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13387.x · Cited by 567 · cited 1×
“In particular, the response to restraint stress is characterized by three related events: 1) activation of the sympathetic nervous system, which leads to an acute release of catecholamines (CATs) (epinephrine and norepinephrine) (1); 2) a slower but more sustained increase in plasma glucocorticoid (GCs) levels (1); an…”
BackgroundAn inflammatory review of glucocorticoid actions in the CNS
Sorrells, S. F., & Sapolsky, R. M. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.11.006 · Cited by 458
Roles of Nuclear Factor κB in Neuronal Survival and Plasticity
Mattson, M. P., Culmsee, C., Yu, Z., & Camandola, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740443.x · Cited by 457
[3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes
Wong, E. H. F., Knight, A. R., & Woodruff, G. N. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb13260.x · Cited by 454 · cited 1×
“5–3 mg/kg) and was based in preceding studies from our laboratory and others (13, 50, 51).”
BackgroundCatecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines
Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., & Fleshner, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.090 · Cited by 424
HEALTH PSYCHOLOGY: Mapping Biobehavioral Contributions to Health and Illness
Baum, A., & Posluszny, D. M. (1999) · Annual Review of Psychology · doi:10.1146/annurev.psych.50.1.137 · Cited by 413 · cited 7×
“• Stress Regulates Prostaglandin Synthesis and PPAR Endocrinology, April 2008, 149(4):1969–1978 1971”
BackgroundMethodInfluentialCyclooxygenase-2: Molecular Biology, Pharmacology, and Neurobiology
O'Banion, M. K. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i1.30 · Cited by 404
Interdomain communication regulating ligand binding by PPAR-γ
Shao, D., Rangwala, S. M., Bailey, S. T., Krakow, S. L., Reginato, M. J., & Lazar, M. A. (1998) · Nature · doi:10.1038/24634 · Cited by 349
Urade, Y., & Hayaishi, O. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00161-8 · Cited by 332 · cited 1×
“In the case of PGE2 synthesis, microsomal PGE2 synthase-1 (m-PGES-1) is the most important and studied E synthase-type enzyme in brain cortex (20), and for 15d-PGJ2 synthesis, lipocalin-type PGD2 synthase (LPGDS) is the main one (21).”
BackgroundRoozendaal, B., McReynolds, J. R., & McGaugh, J. L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4664-03.2004 · Cited by 327 · cited 1×
“The PRO dose range chosen has proven to block adrenergic effects in brain by various studies focused on stress released catecholamines (45, 46).”
BackgroundProtein determination using bicinchoninic acid in the presence of sulfhydryl reagents
Hill, H. D., & Straka, J. G. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90109-1 · Cited by 305 · cited 1×
“Proteins were measured using the bicinchoninic acid method (52).”
MethodRestraint stress in biomedical research: An update
Glavin, G. B., Paré, W. P., Sandbak, T., Bakke, H.-K., & Murison, R. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90027-2 · Cited by 304
Feedback control of cyclooxygenase-2 expression through PPARγ
Inoue, H., Tanabe, T., & Umesono, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001387200 · Cited by 276
Mechanisms and Mediators of Psychological Stress-Induced Rise in Core Temperature
Oka, T., Oka, K., & Hori, T. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200105000-00018 · Cited by 271 · cited 2×
“In this vein, we have demonstrated that, in the presence of high GCs levels, a strong inflammatory response is induced in brain along with the accumulation of oxidative and nitrosative mediators (11).”
BackgroundHeneka, M. T., Klockgether, T., & Feinstein, D. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06862.2000 · Cited by 269
Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation
Castrillo, A., & Tontonoz, P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.134432 · Cited by 260 · cited 1×
“PPAR is a transcription factor that belongs to the superfamily of hormone nuclear receptors (28) widely expressed in brain cortex (29), exerting antiinflammatory activities in brain cells by reducing the release of proinflammatory cytokines, inducible NO synthase (NOS)-2, and COX-2 expression or interfering with infla…”
BackgroundDexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38
Lasa, M., Brook, M., Saklatvala, J., & Clark, A. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.771-780.2001 · Cited by 259 · cited 1×
“Unexpectedly, in our model, the pharmacological inhibition of the synthesis of GCs and the blockade of MR- and GR-dependent actions inhibit prostaglandin synthesis after stress in the brain without affecting COX-2 or specific prostaglandin synthases expression, results that indirectly indicate possible effects of GCs…”
BackgroundChronic Stress Induces the Expression of Inducible Nitric Oxide Synthase in Rat Brain Cortex
Olivenza, R., Moro, M. A., Lizasoain, I., Lorenzo, P., Fernández, A. P., Rodrigo, J., Boscá, L., & Leza, J. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740785.x · Cited by 236 · cited 1×
“degeneration (12), a more complex regulatory role has been”
BackgroundSelf-citationRegulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids.
Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J., & Wahli, W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31420-5 · Cited by 233
Murakami, M., Nakatani, Y., Tanioka, T., & Kudo, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00043-6 · Cited by 232 · cited 1×
“In the case of PGE2 synthesis, microsomal PGE2 synthase-1 (m-PGES-1) is the most important and studied E synthase-type enzyme in brain cortex (20), and for 15d-PGJ2 synthesis, lipocalin-type PGD2 synthase (LPGDS) is the main one (21).”
BackgroundHewett, S. J., Uliasz, T. F., Vidwans, A. S., & Hewett, J. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39251-1 · Cited by 227
Prostaglandins in Health and Disease: An Overview
Miller, S. B. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.03.005 · Cited by 222 · cited 1×
“merous physiological and pathophysiological processes (15).”
National Cancer Institute (2020) · Definitions · doi:10.32388/aqq6w5 · Cited by 220
Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus.
Rettori, V, Gimeno, M., Lyson, K., & McCann, S. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11543 · Cited by 215 · cited 1×
“Emerging literature suggests a predominant antiinflammatory role of CATs in several models of neurotoxicity, a role that seems to be exerted through -adrenergic-type receptors, further confirming our results (55).”
ResultMayer, J. L., Klumpers, L., Maslam, S., De Kloet, E. R., Joëls, M., & Lucassen, P. J. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01455.x · Cited by 181
Kim, E. H., & Surh, Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.030 · Cited by 166
PPAR-γ: therapeutic target for ischemic stroke
Culman, J., Zhao, Y., Gohlke, P., & Herdegen, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.004 · Cited by 162
Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain
Madrigal, J. L. M., Moro, M. A., Lizasoain, I., Lorenzo, P., Fernández, A. P., Rodrigo, J., Boscá, L., & Leza, J. C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300187 · Cited by 155
Self-citationAkaike, A., Kaneko, S., Tamura, Y., Nakata, N., Shiomi, H., Ushikabi, F., & Narumiya, S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91268-8 · Cited by 140
Romera, C., Hurtado, O., Mallolas, J., Pereira, M. P., Morales, J. R., Romera, A., Serena, J., Vivancos, J., Nombela, F., Lorenzo, P., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600438 · Cited by 133
Nakade, Y., Tsuchida, D., Fukuda, H., Iwa, M., Pappas, T. N., & Takahashi, T. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00499.2004 · Cited by 128
Prostaglandin E 2 induces caspase-dependent apoptosis in rat cortical cells
Takadera, T., Yumoto, H., Tozuka, Y., & Ohyashiki, T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02449-1 · Cited by 120
PPARγ as a therapeutic target in central nervous system diseases
Sundararajan, S. S., Jiang, Q., Heneka, M. T., & Landreth, G. E. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.020 · Cited by 118
García‐Bueno, B., Madrigal, J. L. M., Lizasoaín, I., Moro, M. Á., Lorenzo, P. L., & Leza, J. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.007 · Cited by 117
Self-citationStress-Induced Oxidative Changes in Brain
M. Madrigal, J., Garcia-Bueno, B., Caso, J., Perez-Nievas, B., & Leza, J. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706778559327 · Cited by 116
Self-citationNitric Oxide, Stress, and Depression
McLeod, T. M., BS, López-Figueroa, A. L., MD, López-Figueroa, A. M. O., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4268 · Cited by 115 · cited 1×
“(NO) (9, 10) and prostaglandins (PGs) (10, 11) as key medi-”
Feinstein, D. L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503763816481 · Cited by 115
Contrasting Roles of Corticosteroid Receptors in Hippocampal Plasticity
Avital, A., Segal, M., & Richter-Levin, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1628-06.2006 · Cited by 111 · cited 1×
“The dose of SP is in the optimal range to block MR and was selected in base of several previous studies in rats (43, 44).”
BackgroundCOX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.
Hoffmann, C. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374282 · Cited by 110 · cited 1×
“COX-2 is constitutively expressed in only certain tissues (such as the brain cortex) but is up-regulated in a wide variety of cells by cytokines, mitogens, growth factors, and bacterial lipopolysaccharide (19).”
BackgroundZhao, X., Ou, Z., Grotta, J. C., Waxham, M. N., & Aronowski, J. A. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.061 · Cited by 100
García‐Bueno, B., Caso, J. R., Perez‐Nievas, B. G., Lorenzo, P. L., & Leza, J. C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301252 · Cited by 94
Self-citationβ-adrenergic receptors are involved in stress-related behavioral changes
Gorman, A., & Dunn, A. J. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90078-8 · Cited by 94
Nadeau, S., & Rivest, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3370 · Cited by 94
Kim, E. J., Kwon, K. J., Park, J., Lee, S. H., Moon, C., & Baik, E. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10373 · Cited by 89 · cited 1×
“due to the large quantities of free radicals generated by cyclooxygenase activity and also to its principal products like PGE2, which are neurotoxic per se (69–71), although other authors have found certain neuroprotective action for this compound, depending on the type of PGE2 receptor activated (72, 73).”
BackgroundPPAR-γ ligands modulate effects of LPS in stimulated rat synovial fibroblasts
Simonin, M.-A., Bordji, K., Boyault, S., Bianchi, A., Gouze, E., Bécuwe, P., Dauça, M., Netter, P., & Terlain, B. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2002.282.1.c125 · Cited by 85
The Effects of Stress on Homeostasis in JCR-LA-cp Rats: The Role of Nitric Oxide
Leza, J. C., Salas, E., Sawicki, G., Russell, J. C., & Radomski, M. W. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37736-5 · Cited by 81
Self-citationYang, Y., Zheng, X., Wang, Y., Cao, J., Dong, Z., Cai, J., Sui, N., & Xu, L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5544-03.2004 · Cited by 77
Intrinsic Regulation of Brain Inflammatory Responses
Galea, E., Heneka, M. T., Russo, C. D., & Feinstein, D. L. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025084415833 · Cited by 74
Pepicelli, O., Fedele, E., Bonanno, G., Raiteri, M., Ajmone‐Cat, M. A., Greco, A., Levi, G., & Minghetti, L. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00897.x · Cited by 73
Neuroprotective effects of PPARγ agonists against oxidative insults in HT-22 cells
Aoun, P., Watson, D. G., & Simpkins, J. W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01867-3 · Cited by 72
Rotllant, D., Ons, S., Carrasco, J., & Armario, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02120.x · Cited by 65 · cited 1×
“The dose of MET used was chosen based on previous studies showing that this dose is sufficient to block GC synthesis during 24 h after injection; however, a higher single dose of MET (200 mg/kg) causes long-term dysregulation of the HPA axis (ACTH permanent overelease) in the rat (38, 39).”
MethodRelationship between cyclooxygenase‐2 and nitric oxide synthase‐2 in rat cortex after stress
Madrigal, J. L. M., García‐Bueno, B., Moro, M. A., Lizasoain, I., Lorenzo, P., & Leza, J. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02888.x · Cited by 64
Self-citationDhir, A., Padi, S. S. V., Naidu, P. S., & Kulkarni, S. K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.064 · Cited by 64
Théry, C., Dobbertin, A., & Mallat, M. (1994) · Glia · doi:10.1002/glia.440110411 · Cited by 64
Bianchi, A., Moulin, D., Sebillaud, S., Koufany, M., Galteau, M.-M., Netter, P., Terlain, B., & Jouzeau, J.-Y. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1830 · Cited by 58
Ježová, D., Tokarev, D., & Rusnák, M. (1995) · Neuroendocrinology · doi:10.1159/000127021 · Cited by 57 · cited 1×
“5–3 mg/kg) and was based in preceding studies from our laboratory and others (13, 50, 51).”
BackgroundKlotz, L., Sastre, M., Kreutz, A., Gavrilyuk, V., Klockgether, T., Feinstein, D. L., & Heneka, M. T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01909.x · Cited by 51
Tanaka, A., Hatazawa, R., Takahira, Y., Izumi, N., Filaretova, L. P., & Takeuchi, K. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9394-8 · Cited by 51
García‐Bueno, B., Madrigal, J. L. M., Lizasoaín, I., Moro, M. Á., Lorenzo, P. L., & Leza, J. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2195-5 · Cited by 48 · cited 6×
“Adding to the complexity of the GC effects on inflammatory processes, we demonstrate here that the same stress protocol is able to enhance the synthesis of antiinflammatory mediators as 15d-PGJ2 and its nuclear target, PPAR (26, 27), through a mechanism related to both types of glucocorticoid”
BackgroundInfluentialSelf-citationGarcía‐Fernández, L. F., Iñiguez, M. A., Eguchi, N., Fresno, M., Urade, Y., & Muñoz, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750460.x · Cited by 46 · cited 1×
“(65) identified the synthetic glucocorFIG.”
Restraint stress impairs early wound healing in mice via α-adrenergic but not β-adrenergic receptors
Eijkelkamp, N., Engeland, C. G., Gajendrareddy, P. K., & Marucha, P. T. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.11.008 · Cited by 40
Mattsson, C., Lai, M., Noble, J., McKinney, E., Yau, J. L., Seckl, J. R., & Walker, B. R. (2003) · Endocrinology · doi:10.1210/en.2002-221015 · Cited by 39
Immune Changes during Acute Cold/Restraint Stress-Induced Inhibition of Host Resistance to Listeria
Cao, L., Hudson, C. A., & Lawrence, D. A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg146 · Cited by 39 · cited 2×
“The PRO dose range chosen has proven to block adrenergic effects in brain by various studies focused on stress released catecholamines (45, 46).”
BackgroundMethodBugajski, A. J., Gądek-Michalska, A., & Bugajski, J. (2006) · PubMed · Cited by 37
Birkle, D. L., Wright, K. F., Ellis, C. K., & Ellis, E. F. (1981) · Prostaglandins · doi:10.1016/0090-6980(81)90156-8 · Cited by 37
Rotllant, D., & Armario, A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.007 · Cited by 34 · cited 1×
“The dose of MET used was chosen based on previous studies showing that this dose is sufficient to block GC synthesis during 24 h after injection; however, a higher single dose of MET (200 mg/kg) causes long-term dysregulation of the HPA axis (ACTH permanent overelease) in the rat (38, 39).”
MethodKabbaj, M., Piazza, P. V., Simon, H., Moal, M. L., & Maccari, S. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00620-k · Cited by 27
Kabbaj, M., Morley‐Fletcher, S., Moal, M. L., & Maccari, S. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05585.x · Cited by 24 · cited 1×
“Certainly further work is necessary to explain this unexpected emerging role of -adrenergic receptors, but individual differences explain similar findings of the -blocker prazosin on corticosterone levels in control and stressed animals (56).”
ResultCover, P. O., Slater, D. M., & Buckingham, J. C. (2001) · Endocrine · doi:10.1385/endo:16:2:123 · Cited by 23 · cited 1×
“This is a paradoxical result, taking into account the classical therapeutic use of GCs in diverse pathologies (autoimmune diseases, chronic inflammation, or transplant rejection), acting as immunosuppressor and antiinflammatory (mainly due to their capacity to inhibit COX activity) in several body systems, including t…”
BackgroundStimulation of prostaglandin synthesis in rat cerebral cortex via a β-adrenoceptor
Hillier, K., & Templeton, W. W. (1982) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(82)90005-2 · Cited by 13
Stress, medical illness, and depression
Slimmer, L. M., Lyness, J. M., & Caine, E. D. (2001) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2001.9554 · Cited by 11
Beilin, B., Shavit, Y., Dekeyser, F., Itzik, A., & Weidenfeld, J. (2006) · Neuroimmunomodulation · doi:10.1159/000094230 · Cited by 7 · cited 1×
“All these effects decisively contribute to an increase in the susceptibility to cerebral damage after exposure to high GC levels (63).”
Background
Cited by
Lucas, K., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8425-7 · Cited by 466
“Stress responses may augment the DAMP-induced TLR activation [96].”
BackgroundKubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419
Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms
García-Bueno, B., Caso, J. R., & Leza, J. C. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.04.001 · Cited by 280
Self-citation
Metadata
- Authors
- García-Bueno, B., Madrigal, J. L. M., Pérez-Nievas, B. G., & Leza, J. C.
- Affiliations
- Department of Pharmacology, Faculty of Medicine (B.G.-B., B.G.P.-N., J.C.L.) Complutense University, 28040 Madrid, Spain
- Pharmacology and Toxicology Institute, Consejo Superior de Investigaciones Centificas-UCM (J.L.M.M.), Complutense University, 28040 Madrid, Spain
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Leza, Juan Carlos
- ORCID
- Leza, Juan Carlos
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-12-13
- Volume
- 149
- Issue
- 4
- Pages
- 1969-1978
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2158324037
- Cited by
- 97
- References
- 84
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 6 · 2014: 4 · 2013: 10 · 2012: 11
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Ministerio de Ciencia y Tecnología
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- acute restraint stress, prostaglandin E2, PPARγ activation, cyclooxygenase-2, catecholamines, glucocorticoids, NMDA receptor, glutamate, neuroinflammation, anti-inflammatory pathways, cerebral cortex, beta-adrenergic receptors, glucocorticoid receptor, mineralocorticoid receptor
- MeSH terms
- Animals, Brain, Catecholamines, Corticosterone, Glucocorticoids, Male, Prostaglandin-Endoperoxide Synthases, Prostaglandins, Stress, Psychological, Prostaglandin D2, Dinoprostone, Rats, Wistar, Glutamic Acid, Intramolecular Oxidoreductases, PPAR gamma, Rats, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.